Bb Biotech as of Dec. 31, 2017
Portfolio Holdings for Bb Biotech
Bb Biotech holds 30 positions in its portfolio as reported in the December 2017 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Ionis Pharmaceuticals (IONS) | 11.5 | $409M | 8.1M | 50.30 | |
Celgene Corporation | 10.1 | $357M | 3.4M | 104.36 | |
Incyte Corporation (INCY) | 9.9 | $350M | 3.7M | 94.71 | |
Neurocrine Biosciences (NBIX) | 7.5 | $268M | 3.5M | 77.59 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 6.2 | $221M | 1.5M | 149.86 | |
Gilead Sciences (GILD) | 5.6 | $199M | 2.8M | 71.64 | |
Radius Health | 5.1 | $181M | 5.7M | 31.77 | |
Halozyme Therapeutics (HALO) | 4.9 | $173M | 8.5M | 20.26 | |
Sage Therapeutics (SAGE) | 4.8 | $172M | 1.0M | 164.71 | |
Alexion Pharmaceuticals | 4.6 | $162M | 1.4M | 119.59 | |
Esperion Therapeutics (ESPR) | 4.4 | $156M | 2.4M | 65.84 | |
Agios Pharmaceuticals (AGIO) | 4.4 | $156M | 2.7M | 57.17 | |
Alnylam Pharmaceuticals (ALNY) | 3.8 | $134M | 1.1M | 127.05 | |
Juno Therapeutics | 2.5 | $88M | 1.9M | 45.71 | |
Tesaro | 2.4 | $87M | 1.0M | 82.87 | |
Regeneron Pharmaceuticals (REGN) | 2.2 | $77M | 205k | 375.96 | |
Macrogenics (MGNX) | 1.4 | $49M | 2.6M | 19.00 | |
Avexis | 1.3 | $45M | 403k | 110.67 | |
Myovant Sciences | 1.2 | $44M | 3.5M | 12.64 | |
Intra Cellular Therapies (ITCI) | 0.9 | $32M | 2.2M | 14.48 | |
Wave Life Sciences (WVE) | 0.8 | $30M | 856k | 35.10 | |
Intercept Pharmaceuticals In | 0.8 | $28M | 486k | 58.42 | |
Alder Biopharmaceuticals | 0.7 | $26M | 2.3M | 11.45 | |
Voyager Therapeutics (VYGR) | 0.7 | $26M | 1.5M | 16.60 | |
Akcea Therapeutics Inc equities | 0.6 | $22M | 1.2M | 17.36 | |
Five Prime Therapeutics | 0.5 | $18M | 828k | 21.92 | |
Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.4 | $16M | 2.3M | 6.80 | |
Prothena (PRTA) | 0.4 | $13M | 350k | 37.49 | |
Novavax | 0.3 | $10M | 8.3M | 1.24 | |
Achillion Pharmaceuticals | 0.1 | $3.7M | 1.3M | 2.88 |